85 related articles for article (PubMed ID: 6460805)
1. Macrophage surface component gp160: sensitivity to plasmin and other proteases.
Remold-O'Donnell E; Lewandrowski K
J Immunol; 1982 Apr; 128(4):1541-4. PubMed ID: 6460805
[TBL] [Abstract][Full Text] [Related]
2. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
Gibson TL; Cohen P
Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
[TBL] [Abstract][Full Text] [Related]
3. Macrophage component gp160, a major trypsin-sensitive surface glycoprotein.
Remold-O'Donnell E
J Exp Med; 1980 Dec; 152(6):1699-708. PubMed ID: 7452150
[TBL] [Abstract][Full Text] [Related]
4. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
[TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of gp160, the major trypsin-sensitive surface glycoprotein of macrophages.
Remold-O'Donnell E
J Biol Chem; 1982 Jun; 257(11):6600-4. PubMed ID: 7076683
[TBL] [Abstract][Full Text] [Related]
6. Activation of the 92 kDa type IV collagenase by tissue kallikrein.
Desrivières S; Lu H; Peyri N; Soria C; Legrand Y; Ménashi S
J Cell Physiol; 1993 Dec; 157(3):587-93. PubMed ID: 8253870
[TBL] [Abstract][Full Text] [Related]
7. Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage.
Poon IK; Olsson AK; Hulett MD; Parish CR
Biochem J; 2009 Oct; 424(1):27-37. PubMed ID: 19712047
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
9. Characterization of plasmin-induced platelet aggregation.
Watabe A; Ohta M; Matsuyama N; Mizuno K; el Borai N; Tanimoto T; Kawanishi T; Hayakawa T
Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):341-52. PubMed ID: 9261893
[TBL] [Abstract][Full Text] [Related]
10. LTBP-1 blockade in dioxin receptor-null mouse embryo fibroblasts decreases TGF-beta activity: Role of extracellular proteases plasmin and elastase.
Gomez-Duran A; Mulero-Navarro S; Chang X; Fernandez-Salguero PM
J Cell Biochem; 2006 Feb; 97(2):380-92. PubMed ID: 16187295
[TBL] [Abstract][Full Text] [Related]
11. Migration inhibition factor-like activity in inflammatory synovial fluids might be due to proteases.
Geiger C; Vischer TL
Clin Exp Immunol; 1976 Oct; 26(1):176-80. PubMed ID: 793749
[TBL] [Abstract][Full Text] [Related]
12. Proteolysis of gelatin-bound fibronectin by activated leukocytes: a role for leukocyte elastase.
Daudi I; Gudewicz PW; Saba TM; Cho E; Vincent P
J Leukoc Biol; 1991 Oct; 50(4):331-40. PubMed ID: 1655937
[TBL] [Abstract][Full Text] [Related]
13. Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments.
Wetsel RA; Kolb WP
J Exp Med; 1983 Jun; 157(6):2029-48. PubMed ID: 6222137
[TBL] [Abstract][Full Text] [Related]
14. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
15. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
[TBL] [Abstract][Full Text] [Related]
16. An assay for high-sensitivity detection of thrombin activity and determination of proteases activating or inactivating protease-activated receptors.
Altrogge LM; Monard D
Anal Biochem; 2000 Jan; 277(1):33-45. PubMed ID: 10610687
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor.
Towle MJ; Lee A; Maduakor EC; Schwartz CE; Bridges AJ; Littlefield BA
Cancer Res; 1993 Jun; 53(11):2553-9. PubMed ID: 8495419
[TBL] [Abstract][Full Text] [Related]
18. Plasmin proteolysis of endothelial cell and vessel wall associated tissue factor pathway inhibitor.
Stalboerger PG; Panetta CJ; Simari RD; Caplice NM
Thromb Haemost; 2001 Sep; 86(3):923-8. PubMed ID: 11583328
[TBL] [Abstract][Full Text] [Related]
19. Alterations in membrane-associated CD14 expression and the simultaneous liberation of soluble CD14 fragment in adherent macrophages mediated by a leukocyte carboxyl/aspartate protease.
Coyne CP; Howell T; Smodlaka H; Willetto C; Fenwick BW; Chenney E
J Endotoxin Res; 2002; 8(4):273-83. PubMed ID: 12230917
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-mediated inhibition of proteolytic enzymes produced by human trophoblast in culture.
Milwidsky A; Finci-Yeheskel Z; Yagel S; Mayer M
J Clin Endocrinol Metab; 1993 May; 76(5):1101-5. PubMed ID: 7684389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
